In the UniProt database alone, there are more than 30 potential EGFR mutations that have been linked to the development of lung cancer, distinguishing two primary types of mutations that could lead to pro-tumorigenic activity: alterations to the extracellular domain and accidental changes to the kinase domain. This evidence concerns the gene EGFR and lung cancer.